Cellectis S.A. (CLLS) Free cash flow 2016–2025
Cellectis S.A. (CLLS) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$41.8MFY2025 · since FY2016: -$46.4M → -$41.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$41.8M | -304.7% |
| FY2024 | $20.4M | +179.0% |
| FY2023 | -$25.8M | +71.3% |
| FY2022 | -$89.9M | +27.0% |
| FY2021 | -$123.1M | +1.0% |
| FY2020 | -$124.3M | -51.5% |
| FY2019 | -$82.1M | -12.6% |
| FY2018 | -$72.9M | -33.2% |
| FY2017 | -$54.7M | -17.9% |
| FY2016 | -$46.4M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More CLLS financial trends
CLLS RevenueCLLS Net incomeCLLS Net marginCLLS Gross profitCLLS Gross marginCLLS Operating incomeCLLS Operating marginCLLS Operating cash flowCLLS Capital expendituresCLLS Return on equityCLLS Stock buybacksCLLS Dividends paidCLLS Total assetsCLLS Total liabilitiesCLLS Shareholders’ equityCLLS overview →